Figure 5From: Antitumor activity of sorafenib-incorporated nanoparticles of dextran/poly(dl-lactide-co-glycolide) block copolymerGrowth inhibition of HuCC-T1 cells by treatment of sorafenib-incorporated Dex b LG nanoparticles. Two thousand cells were exposed to sorafenib, empty nanoparticles, and sorafenib-incorporated nanoparticles for 48 h.Back to article page